Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna Stock Is Rising. Sales Fell a Bit Less Than Expected in 2023.
11:25am, Monday, 08'th Jan 2024
Covid-19 vaccine maker Moderna said 2023 product sales hit $6.7 billion, above the company's guidance, but down more than 60% from 2022.
Moderna's stock rises on 2023 product sales of $6.7B
07:51am, Monday, 08'th Jan 2024
Moderna Inc.'s stock MRNA, +2.26% was up by 1.2% after the drug maker said it sold $6.7 billion of products in 2023. Analyst expected the company to sell $6.35 billion in products in 2023.
Moderna's 2023 prelim COVID vaccine sales meet target
07:05am, Monday, 08'th Jan 2024
Moderna on Monday reported preliminary 2023 sales of $6.7 billion for its COVID vaccine, surpassing the lower end of its full-year forecast, while reiterating its goal of returning to sales growth in
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecast
07:00am, Monday, 08'th Jan 2024
Moderna's sales show the steep drop in demand for Covid products as cases and public concern about the virus dwindled front their pandemic peaks.
Moderna's Flu/COVID Vaccine Prospects Are Undervalued By The Market
10:50am, Sunday, 07'th Jan 2024
Moderna's mRNA-1083 vaccine, targeting COVID-19 and flu, in Phase 3, reflects innovation in combination vaccinations. Despite recent financial losses, Moderna maintains strong liquidity with $12.8 bil
Are defensive sectors ready to outshine growth in 2024?
07:50am, Saturday, 06'th Jan 2024
The Health Care Select Sector SPDR Fund NYSEARCA: XLV, which has both growth and defensive characteristics, was the leader in the first week of the year. Top sector performers included Moderna Inc. NA
Jim Cramer looks at the worst Nasdaq performers of 2023
07:58pm, Thursday, 04'th Jan 2024
'Mad Money' host Jim Cramer looks back at last year's worst performers on the Nasdaq.
Moderna (MRNA) Ascends While Market Falls: Some Facts to Note
07:35pm, Thursday, 04'th Jan 2024
Moderna (MRNA) closed the most recent trading day at $108.66, moving +0.07% from the previous trading session.
Time to Buy Moderna-Heavy ETFs on Vaccine Optimism?
09:02am, Thursday, 04'th Jan 2024
Shares of Moderna witnessed a significant increase of more than 13% on Jan 2, 2024, driven by Oppenheimer's decision to upgrade the stock to "outperform," as quoted on CNBC.
Why Moderna (MRNA) Stock Price Was Up 13% on Tuesday
03:02pm, Wednesday, 03'rd Jan 2024
Moderna (MRNA) surges after analysts at Oppenheimer upgraded its rating in anticipation of the company marketing five products by 2026.
Moderna (MRNA) Moves 13.1% Higher: Will This Strength Last?
11:20am, Wednesday, 03'rd Jan 2024
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Moderna stock upgraded to outperform by Oppenheimer & Co
06:03pm, Tuesday, 02'nd Jan 2024
Oppenheimer & Co Analyst, Hartaj Singh, recently upgraded Moderna (MRNA) shares to "Outperform," with a price target of $142 per share. News of the upgrade has caused shares of the stock to trade over
Three-Stock Lunch: Apple, Tesla and Moderna
03:25pm, Tuesday, 02'nd Jan 2024
Quint Tatro, Joule Financial president, joins 'Power Lunch' to discuss three stocks, including Apple, Tesla and Moderna.
Moderna Stock Surges on Optimism of Bringing More Products to Market
02:50pm, Tuesday, 02'nd Jan 2024
Moderna Inc. (MRNA) shares soared 15% Tuesday as the vaccine maker got two pieces of positive news.
2 Major Reasons Why Moderna (MRNA) Stock Is Up Today
01:45pm, Tuesday, 02'nd Jan 2024
The biotech sector has been hit hard in recent years. Among the most disappointing stocks for growth investors in this space has certainly been Moderna (NASDAQ: MRNA ), an RNA-based vaccine maker that
